Fundraising Fox

Henry Skinner

Investor

Chief Executive Officer at AMR Action Fund

About

Microbiologist, venture investor, and executive focused on antimicrobial drug development. Previously SVP Venture at Tekla Capital Management and Deputy Head/Managing Director of the Novartis Venture Fund, and CEO of SelectX and NeoGenesis Pharmaceuticals.

Deals · 1

Trellis BioscienceQuoted

via AMR Action Fund · filed Jan 2026

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at AMR Action Fund

Bill Burns
Board Chair at AMR Action Fund
Carly Levine
Senior Associate at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund